Health

Group B Streptococcus Vaccine: full value vaccine assessment – World Health Organization

The purpose of this report, WHO Full value of vaccines assessment of Group B streptococcus vaccines, is to describe the global…

Published

4 years ago

November 3, 2021

Noosa Online News Publisher

Overview
Group B streptococcus (GBS) is an important cause of disease
burden in every region worldwide, contributing to neonatal/
infant infection, deaths, disability, stillbirths and maternal infection. The World Health Organization (WHO) identified…

Click here to view the original article.

Related Topics:Australia World Health Organization

Up Next

Deaths from smoking-related cancers expected to increase in China over the next 20 years – News-Medical.Net – Port Macquarie Online News

Don't Miss

25 Zika virus cases reported in Kanpur, special ward set up in hospital – Lokmat

Noosa News24 hours ago

After Hours Gallery Visits, French Dining and Garden Illuminations: Your Guide to the Ultimate Melbourne Culture Fix

General17 hours ago

Top chess player Magnus Carlsen forced into draw in historic game against over 134,000 people

Business17 hours ago

Is Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?

General21 hours ago

Death of 86-year-old driver in Karoonda Highway crash prompts push for change

Noosa Online News

Group B Streptococcus Vaccine: full value vaccine assessment – World Health Organization

Trending